Michael Smith is an accomplished professional in the biopharmaceutical industry with extensive experience in drug product development and nanoparticle formulation. Currently serving as a Director at Moderna since April 2014, previous roles include Associate Director, Principal Scientist, and Senior Scientist. At Merck, Michael contributed as a Senior Scientist, focusing on siRNA lipid nanoparticles and formulation optimization. Michael's academic background includes a PhD in Chemistry from Georgia Institute of Technology, where research involved nano-sized hydrogels for cancer therapy, as well as participation in the TI:GER program. Prior internship experiences at Wyeth Research and Wyeth Pharmaceuticals provided foundational insights in clinical trial operations and quality control.
This person is not in the org chart
This person is not in any teams
This person is not in any offices